Institutional and public shareholders
Biotech Investor · 3 portfolio companies
Portfolio
3
Combined Value
$2.8B
Focus Areas
8
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Innoviva | $1.6B |
| SELLAS Life Sciences | $854.6M |
| XOMA | $355.5M |